Preparation of the Traditional Chinese Medicine Compound Recipe Heart-Protecting Musk pH-Dependent Gradient-Release Pellets

REFERENCES

• Feng N.P., Zhang Z.X. Development of Traditional Chinese Drug Dosage Forms. Chin. Trad. Herb. Drugs 1997; 28: 306–308
   Google Scholar
• Chinese Pharmacopoeia Commission. ShenxiangBaoxin Wan. First Section of Pharmacopoeia of the People's Republic of China 2000 Edition. Chemical Industry Press, Beijing 2000; 635–636
   Google Scholar
• Wang S.Y., Dai R.H., Jin C., Luo H.M., Chen S.X., Chen M.F., Xu J.M. Clinical Observation of ShenxiangBaoxin Wan for Treatment of Coronary Heart Disease with Angina Pectoris. Chin. J. Integr. Med. 1996; 16: 717–720
   Google Scholar
• Zeng X.M. Effects of Inorganic Salts on Adsorption of Total Ginsenoside in Macroporous Polymeric Adsorbent. Chin. J. Pharm. 1992; 23: 339–341
   Google Scholar
• Song H.T., Guo T., Yan X.T., Zhang Q., Zhang R.H. Studies on the Preparation of Cinnamon Oil-β-Cyclodextrin Inclusion Complex. Chin. Trad. Herb. Drugs 2000; 31: 818–820
   Google Scholar
• Song H.T., Guo T., Yan X.T., Zhang Q., Zhang R.H. Study on the Preparation of Styrax-β-Cyclodextrin Inclusion Complexes. Chin. Hosp. Pharm. J. 2001; 21: 143–145
   Google Scholar
• Song H.T., Guo T., Qin D.Y., Zhao M.H., Zhang R.H. The Preparation of Borneol-β-Cyclodextrin Inclusion Complexes. J. Shenyang Pharm. Univ. 2000; 17: 170–173
   Google Scholar
• Qin D.Y., Song H.T., Guo T., Zhang Y.X., Zhang L.H. Studies on the Stability of Borneol-β-Cyclodextrin Inclusion Complex. Chin. Trad. Herb. Drugs 2000; 31: 255–257
   Google Scholar
• Song H.T., Guo T., Yan X.T., Zhang Q., Zhang R.H. The Stabilities of Inclusion Complex of Styrax-β-Cyclodextrin. Pharm. J. Chin. PLA 2000; 16: 163–165
   Google Scholar
• Guo T., Song H.T., Yan X.T., Yu K.J., Zhang R.H. Studies on the Stability of Inclusion Complex of Cinnamon Oil-β-Cyclodextrin. China J. Chin. Mater. Med. 2000; 25: 411–413
   Google Scholar
• Song H.T., Guo T., Qin D.Y., Zhang R.H., Bi K.S. The Stabilities of Artificial Moschus-β-Cyclodextrin Inclusion Complex. Chin. Pharm. J. 2002; 37: 673–675
   Google Scholar
• Evans D.F., Pye G., Bramley R., Clark A.G., Dyson T.J., Hardcastle J.D. Measurement of Gastrointestinal pH Profiles in Normal Ambulant Human Subjects. Gut 1988; 29: 1035–1041
   PubMed Web of Science ®Google Scholar
• Watts P.J., IIIum L. Colonic Drug Delivery. Drug Dev. Ind. Pharm. 1997; 23: 893–913
   Web of Science ®Google Scholar
• Davis S.S., Hardy J.G., Taylor M.J., Whalley D.R., Wilson C.G. A Comparative Study of the Gastrointestinal Transit of a Pellet and Tablet Formulation. Int. J. Pharm. 1984; 21: 167–177
   Web of Science ®Google Scholar
• John G.H., Clive G.W., Elizabeth W. Drug Delivery to the Proximal Colon. J. Pharm. Pharmacol. 1985; 37: 874–877
   PubMed Web of Science ®Google Scholar
• Devereux J.E., Newton J.M., Short M.B. The Influence of Density on the Gastrointestinal Transit of Pellets. J. Pharm. Pharmacol. 1990; 42: 500–501
   PubMed Web of Science ®Google Scholar
• Yuen K.H., Deshmukh A.A., Newton J.M., Short M., Melchor R. Gastrointestinal Transit and Absorption of Theophylline from a Multiparticulate Controlled Release Formulation. Int. J. Pharm. 1993; 97: 61–77
   Web of Science ®Google Scholar
• Clarke G.M., Newton J.M., Short M.B. Comparative Gastrointestinal Transit of Pellet Systems of Varying Density. Int. J. Pharm. 1995; 114: 1–11
   Web of Science ®Google Scholar
• Podczeck F., Newton J.M., Yuen K.H. The Description of the Gastrointestinal Transit of Pellets Assessed by Gamma Scintigraphy Using Statistical Moments. Pharm. Res. 1995; 12: 376–379
   PubMed Web of Science ®Google Scholar
• Abrahamsson B., Alpsten M., Jonsson U.E., Lundberg P.J., Sandberg A., Sundgren M., Svenheden A., Tölli J. Gastrointestinal Transit of a Multiple-Unit Formulation (Metoprolol CR/zok) and a Non-disintegrating Tablet with the Emphasis on Colon. Int. J. Pharm. 1996; 140: 229–235
   Web of Science ®Google Scholar
• Khan M.Z.I., Prebeg Ž., Kurjaković N. A pH-Dependent Colon-Targeted Oral Drug Delivery System Using Methacrylic Acid Copolymers. I. Manipulation of Drug Release Using Eudragit L100-55 and Eudragit S100 Combinations. J. Contr. Rel. 1999; 58: 215–222
   PubMed Web of Science ®Google Scholar
• Khan M.Z.I., Štedul H.P., Kurjaković N. A pH-Dependent Colon-Targeted Oral Drug Delivery System Using Methacrylic Acid Copolymers. II. Manipulation of Drug Release Using Eudragit L100 and Eudragit S100 Combinations. Drug Dev. Ind. Pharm. 2000; 26: 549–554
   PubMed Web of Science ®Google Scholar
• Kislaliogiu M.S., Khan M.A., Blount C., Goettsch R.W., Bolton S. Physical Characterization and Dissolution Properties of Ibuprofen:Eudragit Coprecipitates. J. Pharm. Sci. 1991; 80: 799–804
   PubMed Web of Science ®Google Scholar
• Pillay V., Fassihi R. Evaluation and Comparison of Dissolution Data Derived from Different Modified Release Dosage Forms: An Alternative Method. J. Contr. Rel. 1998; 55: 45–55
   PubMed Web of Science ®Google Scholar
• Moore J.W., Flanner H.H. Mathematical Comparison of Dissolution Profiles. Pharm. Tech. 1996; 20: 64–74
   Google Scholar
• Polli J.E., Rekhi G.S., Augsburger L.L., Shah V.P. Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate Tablets. J. Pharm. Sci. 1997; 86: 690–700
   PubMed Web of Science ®Google Scholar
• Odani T., Tanizawa H., Takino Y. Studies on the Absorption, Distribution, Excretion and Metabolism of Ginseng Saponins. IV. Decomposition of Ginsenoside-Rg1 and Rb1 in the Digestive Tract of Rats. Chem. Pharm. Bull. 1983; 31: 3691–3697
   PubMed Web of Science ®Google Scholar